Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare's positive outlook is supported by its strategic investment in the USPI segment, which is characterized by higher growth rates, margins, and returns, contributing to an expected increase in income from equity earnings in 2026. The company's competitive positioning is strengthened through improvements in cost structure, growth opportunities in outpatient services, and a favorable payer mix, all of which are anticipated to enhance enterprise-wide margin expansion. Strong demand and volume, alongside cost-saving measures, further emphasize the visible transformation within Tenet Healthcare, with the USPI segment expected to significantly drive margin and multiple expansion in the coming years.

Tenet Healthcare's stock outlook is negatively impacted by key financial headwinds, including anticipated subsidy expirations that are projected to reduce revenue by $220 million in its Acute segment and $30 million in the USPI segment for 2026. The company's recent recognition of $148 million in non-recurring Medicaid state funds in 2025, while beneficial in the short term, does not offset the substantial potential losses expected from the decline in HIX coverage, with a predicted 20% decrease leading to increased uninsured rates. Furthermore, the reliance on historically low valuation levels near 7x EBITDA signals a disconnect between market perception and the company's underlying financial performance, indicating systemic challenges ahead.